Enochian BioSciences Shares Halted On Circuit Breaker To Downside; Co Announces $29M Offering
LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- (NASDAQ:ENOB) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it
Energy Focus Announces $5M Registered Direct Offering Priced-At-The-Market
Energy Focus, Inc. ("Energy Focus," "we," "our," "us" or the "Company") (NASDAQ:EFOI), a leader in sustainable and human-centric lighting ("HCL") technologies
Avalon GloboCare Adds Cell Therapy-Based Candidates For Cancer With SenlangBio Acquisition: Highlights
Avalon GloboCare Corp (NASDAQ:AVCO) has agreed to acquire Hebei Senlang Biotechnology, dubbed SenlangBio, a China-based cell therapy company, in an all-stock…
Recon Technology Prices Registered Direct Offering For Gross Proceeds Of $55M
Recon Technology, Ltd. (NASDAQ:RCON) ("Recon" or the "Company") announced today it has entered into a securities purchase agreement with certain accredited investors on June 14, 2021 to
Peter Thiel-Backed Psychedelic Firm Atai Sets Terms For US IPO, Sees $2.3B Valuation
Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, has announced terms for its initial public offering.